Back to Search Start Over

18 F-Fluorocholine Positron Emission Tomography/Computed Tomography is a Highly Sensitive but Poorly Specific Tool for Identifying Malignancy in Thyroid Nodules with Indeterminate Cytology: The Chocolate Study.

Authors :
Ciappuccini R
Licaj I
Lasne-Cardon A
Babin E
de Raucourt D
Blanchard D
Bastit V
Saguet-Rysanek V
Lequesne J
Peyronnet D
Grellard JM
Clarisse B
Bardet S
Source :
Thyroid : official journal of the American Thyroid Association [Thyroid] 2021 May; Vol. 31 (5), pp. 800-809. Date of Electronic Publication: 2020 Dec 23.
Publication Year :
2021

Abstract

Background: Refining the risk of malignancy in patients presenting with thyroid nodules with indeterminate cytology (IC) is a critical challenge. We investigated the performances of <superscript>18</superscript> F-fluorocholine (FCH) positron emission tomography/computed tomography (PET/CT) to predict malignancy. Methods: Between May 2016 and March 2019, 107 patients presenting with a thyroid nodule ≥15 mm with IC and eligible for surgery were included in this prospective study. Head-and-neck PET/CT acquisitions were performed 20 and 60 minutes after injection of 1.5 MBq/kg of FCH. PET/CT acquisition was scored positive when maximal standardized uptake value in the IC nodule was higher than in the thyroid background. Pathology was the gold standard for diagnosis. Results: At pathology, 19 (18%) nodules were malignant, 87 were benign, and one was a noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Sensitivity, specificity, accuracy, positive-predictive value (PPV), and negative-predictive value (NPV) of FCH PET/CT in detecting cancer or NIFTP were 90%, 50%, 55%, 29%, and 96% at 20 minutes and 85%, 49%, 67%, 28%, and 94% at 60 minutes, respectively. Higher specificity (58% vs. 33%, p  = 0.01) was observed in nononcocytic ( n  = 72) than in oncocytic IC nodules ( n  = 35). The pre-PET/CT probability of cancer or NIFTP in Bethesda III-IV nodules was 11% and the post-PET/CT probability was 19% in PET-positives and 0% in PET-negatives. In retrospective analysis, 42% of surgeries would have been unnecessary after PET/CT and 81% before ( p  < 0.001), resulting in a hypothetical 48% reduction (95% confidence interval [32-64]). Conclusions: FCH PET/CT offers high NPV to reliably exclude cancer in PET-negative IC nodules, but suffers from low PPV, particularly in those with oncocytic cytology. ClinicalTrials.gov identifier: NCT02784223.

Details

Language :
English
ISSN :
1557-9077
Volume :
31
Issue :
5
Database :
MEDLINE
Journal :
Thyroid : official journal of the American Thyroid Association
Publication Type :
Academic Journal
Accession number :
33183159
Full Text :
https://doi.org/10.1089/thy.2020.0555